Study of BLU-808 in Allergic Rhinoconjunctivitis

Clinical trial NCT06922448 · COMPLETED

Trial details

NCT number: NCT06922448
Sponsor: Blueprint Medicines Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinoconjunctivitis

Start date: 2025-04-14
Primary completion: 2025-09-08
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.